BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2155124)

  • 21. Two distinct populations of [3H]prazosin and [3H]yohimbine binding sites in the plasma membranes of rat mesenteric artery.
    Agrawal DK; Daniel EE
    J Pharmacol Exp Ther; 1985 Apr; 233(1):195-203. PubMed ID: 2984413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
    Ohmura T; Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]-RS-15385-197, a selective and high affinity radioligand for alpha 2-adrenoceptors: implications for receptor classification.
    MacKinnon AC; Kilpatrick AT; Kenny BA; Spedding M; Brown CM
    Br J Pharmacol; 1992 Aug; 106(4):1011-8. PubMed ID: 1327384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased affinity and preference of halogenated derivatives of BE 2254 for alpha 1-adrenoceptors demonstrated by functional and binding experiments.
    Schlicker E; Brodde OE; Göthert M; Schaperdoth M
    J Cardiovasc Pharmacol; 1984; 6(6):1238-44. PubMed ID: 6084785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of alpha 1-adrenoceptors in rat renal cortex: comparison of [3H]-prazosin binding with the alpha 1-adrenoceptor modulating gluconeogenesis under physiological conditions.
    McPherson GA; Summers RJ
    Br J Pharmacol; 1982 Sep; 77(1):177-84. PubMed ID: 6127133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of [3H]-prazosin and [3H]-dihydroergocryptine to rat cardiac alpha-adrenoceptors.
    Guicheney P; Meyer P
    Br J Pharmacol; 1981 May; 73(1):33-9. PubMed ID: 6269682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective blockade of alpha 1-adrenoceptors of porcine vascular smooth muscle cells by bunazosin.
    Nishimura J; Kanaide H; Miwa-Nishimura N; Nakamura M
    Arzneimittelforschung; 1989 Jun; 39(6):668-9. PubMed ID: 2570581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developmental changes in alpha 1-adrenoceptor coupling to G-protein in bovine aorta.
    Jagadeesh G; Tian WN; Gupta S; Deth RC
    Eur J Pharmacol; 1990 Jul; 189(1):11-21. PubMed ID: 1977601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solubilization of active brain alpha 1-adrenoceptors by a zwitterionic detergent.
    Guicheney P; Rappaport A; Marcel D
    J Neurochem; 1983 Jul; 41(1):56-61. PubMed ID: 6306172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The modulatory role of vascular endothelium in the interaction of agonists and antagonists with alpha-adrenoceptors in the rat aorta.
    Alosachie I; Godfraind T
    Br J Pharmacol; 1988 Oct; 95(2):619-29. PubMed ID: 2906562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for multiple [3H]prazosin binding sites in canine brain membranes.
    Mignot E; Bowersox SS; Maddaluno J; Dement W; Ciaranello R
    Brain Res; 1989 May; 486(1):56-66. PubMed ID: 2541871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selectivity of benzodioxane alpha-adrenoceptor antagonists for alpha 1- and alpha 2-adrenoceptors determined by binding affinity.
    Timmermans PB; van Kemenade JE; Batink HD; van Zwieten PA
    Pharmacology; 1983; 26(5):258-69. PubMed ID: 6134295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different affinity states of alpha-1 adrenergic receptors defined by agonists and antagonists in bovine aorta plasma membranes.
    Jagadeesh G; Deth RC
    J Pharmacol Exp Ther; 1987 Nov; 243(2):430-6. PubMed ID: 2890755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological subclassification of alpha 1-adrenoceptors in vascular smooth muscle.
    Muramatsu I; Ohmura T; Kigoshi S; Hashimoto S; Oshita M
    Br J Pharmacol; 1990 Jan; 99(1):197-201. PubMed ID: 1970493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agonist-induced modulation of agonist binding to alpha 1-adrenoceptors in bovine aorta.
    Jagadeesh G; Tian WN; Deth RC
    Eur J Pharmacol; 1991 Oct; 208(2):163-70. PubMed ID: 1686866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-1 adrenoceptors: evaluation of receptor subtype-binding kinetics in intact arterial tissues and comparison with membrane binding.
    Tanaka T; Zhang L; Suzuki F; Muramatsu I
    Br J Pharmacol; 2004 Feb; 141(3):468-76. PubMed ID: 14718262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of imidazolines with alkylation-sensitive and -resistant alpha-1 adrenoceptor subtypes.
    Piascik MT; Sparks MS; Pruitt TA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):158-65. PubMed ID: 1677036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha adrenoceptor sites in vascular smooth muscle. Differentiation by selective antagonist binding.
    Cheung YD; Triggle CR
    Biochem Pharmacol; 1988 Nov; 37(21):4055-61. PubMed ID: 2847751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of alpha 1-adrenoceptor subtype selectivity by [3H]-prazosin displacement studies in guinea-pig cerebral cortex and rat spleen membranes.
    Veenstra DM; van Buuren KJ; Nijkamp FP
    Br J Pharmacol; 1992 Sep; 107(1):202-6. PubMed ID: 1358383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors.
    Greengrass P; Bremner R
    Eur J Pharmacol; 1979 May; 55(3):323-6. PubMed ID: 37098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.